1,5-BENZODIAZEPINE DERIVATIVES AS ACK-A RECEPTOR AGONISTS

摘要

An enantiomerically enriched compound of Formula (I) is disclosed, processes for its preparation, pharmaceutical compositions containing it and the use therefore, for the treatment of CCK-A mediated diseases or conditions, such as obesity.